Bio-path (BPTH) Acute Myeloid Leukemia Treatment Granted FDA Orphan Drug Designation
Tweet Send to a Friend
Bio-path's (NASDAQ: BPTH) acute myeloid leukemia treatment has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
